Updated employee announcements, business news, awards, and recognition in the industry today.
People News
PAREXEL, an provider of biopharmaceutical services, announced the appointment of Greg Rush as Executive Vice President and Chief Financial Officer and Michele Fournier as Senior Vice President and Chief Human Resources Officer.
uMotif, a company that provides a data capture platform for research, is pleased to announce the appointment of Andrew McDonagh as Chief Technology Officer.
Certara, a drug development consultancy, announced that it has appointed Mark Holbrook, PhD, to the newly-created position of Vice President of Quantitative Systems Toxicology and Safety.
ZRG Partners, a global executive search firm, announced that Alex Bennett has joined as a Managing Director and Chief Growth Officer.
Saama Technologies, Inc., a data analytics company, announced the addition of six new members to its Clinical Board of Advisors. The new members include Opinder Bawa,Vice President and Chief Information Officer, Stephen Cunningham, M.D., President, SRC Pharma Consult, John J. Fox,Vice President, Global Payroll, Johnson & Johnson and Vice President of Information Technology, Pharmaceuticals Group, Scot Harper, Ph.D., President, SLH Group, LLC, Jay Kaminski, Chief Operating Officer, Celularity, and Jonathan Zung, Ph.D., President, Clintrax.
Business News
Veeva Systems announced that more than 65 medical devices and diagnostics companies are adopting Veeva Vault applications to streamline content and data management in clinical, quality, and commercial.
Recognition
Greenphire, a provider of financial software for clinical trials, announced that it has been named to the 2018 Inc. 5000 list, an honor it has now earned six years in a row which highlights the most successful companies within the American economy’s most dynamic segment.
Rho, a full-service CRO, announced that the Triangle Business Journal has ranked the company as the number one extra-large company.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.